News | February 25, 2019

Almac Group Engages With Science Exchange To Promote US Small Molecule Analytical Services

Source: Almac Group

Almac Sciences, a member of the Almac Group, has announced a collaboration with Science Exchange, the world’s leading R&D Services Management company. The partnership will offer online access to Almac’s integrated services from development through commercial scale production of active pharmaceutical ingredients to clients worldwide.

Almac Sciences has profiled its service offerings on the Science Exchange website, including the recently announced full suite of analytical services now offered from its European and North American facilities. Employing 150 highly skilled analysts working in GMP / GLP environments, Almac is positioned as the partner of choice with significant experience in the analysis of both small and large molecules and a range of product types including peptides, biologics, conjugates, potents and controlled substances.

Science Exchange was founded in 2011 with the mission of democratising access to the world’s scientific expertise in order to move the research world forward at a faster pace. Science Exchange’s secure online solution to manage R&D services makes it easy for researchers to access the world’s leading scientific service providers and most innovative technologies.

“Science Exchange gives Almac Sciences another avenue where potential clients can find us in a quick and efficient manner,” says Denis Geffroy, VP Business Development, Almac Sciences. “This unique platform will enable us to provide added value across the clinical development lifecycle and help drive our clients to R&D success.”

Elizabeth Iorns, Ph.D., CEO and Co-Founder of Science Exchange, commented, “We are delighted that Almac has chosen to profile its offerings on our marketplace, where researchers from across the globe can readily access details on Almac’s vast range of services. Clients can use our platform to order services directly from Almac under a single, pre-established contract, enabling them to save time and money.”

About Almac Group
A unique culture delivering exceptional solutions

The Almac Group is an established contract development and manufacturing organisation providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally.

Innovative services range from R&D, biomarker discovery development and commercialisation, API manufacture, formulation development, clinical trial supply, IRT (IVRS/IWRS) through to commercial-scale manufacture.

The international company is a privately owned organisation that has grown organically over the past five decades now employing over 5,000 highly skilled personnel across 17 facilities including Europe, the US and Asia. For more information, visit

About Science Exchange, Inc.
Science Exchange is the world’s leading R&D Services Management company, empowering research organizations to accelerate science and drive more innovation success.

With a secure online solution to manage the complete R&D services eCommerce workflow, Science Exchange offers more than 7,000 services from a network of over 2,500 qualified research providers. For more information, visit

Source: Almac Group